InMode Ltd. INMD
Biotechnology: Electromedical & Electrotherapeutic Apparatus · IPO 2019 · data as of November 13, 2026
InMode Ltd. (INMD) is a healthcare company listed in the US with a market value of about $763M. In the twelve months to September 30, 2026 it had revenue of $374M and net income of $75M, a net margin of 19.9%.
Its overall Stock Analiz score is 2.8 out of 5 (average). The strongest part is value (5/5); the weakest is future growth (0/5).
Key numbers: a P/E of 11.0, a price to free cash flow of 11.0, 5-year revenue growth of 12% a year, a 5-year average ROIC of 23%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 22% above the current price.
About InMode
InMode is listed in the US and classified in biotechnology: electromedical & electrotherapeutic apparatus, IPO year 2019. Revenue went from $53M in 2017 to $370M in 2025, growth of about 27.4% a year. It was profitable in 9 of the last 9 years in our data. It spends 4% of revenue on research and development.
Score: 2.8 / 5
Checks passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- 5-year revenue growth above 8% a year
- 5-year average ROIC above 12%
- Profitable 5 years in a row
Checks not passed
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year EPS growth above 10% a year
- ROE above 15%
- Pays a dividend
Valuation
Growth and quality
Financials, last 9 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $374M | $370M | $395M | $492M | $454M | $358M | $206M | $156M | $100M | $53M |
| Net income | $75M | $94M | $181M | $198M | $162M | $165M | $75M | $61M | $22M | $9M |
| Free cash flow | $69M | $84M | $132M | $176M | $180M | $174M | $79M | $62M | $37M | $14M |
| EPS (diluted) | $1.21 | $1.63 | $3.15 | $3.44 | $2.81 | $2.87 | $1.31 | $1.06 | $0.39 | $0.15 |
| Net margin | 19.9% | 25.3% | 45.9% | 40.2% | 35.6% | 46.1% | 36.4% | 39.1% | 22.3% | 16.5% |
| ROIC | — | 10.5% | 12.5% | 22.4% | 28.3% | 39.1% | 28.1% | 33.1% | 51.4% | 41.4% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 3 analysts is $14.67, 11% above the current price; targets range from $14.00 to $15.00; the consensus rating is “Hold”; expected EPS is $1.32 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is InMode’s P/E ratio?
About 11.0, based on the last twelve months of diluted earnings per share (forward P/E about 10.2).
Is InMode stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 22% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does InMode pay a dividend?
Not currently.
Is InMode a good stock to buy?
We do not give buy or sell advice. InMode scores 2.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.